Shin-San Michael Su, Ph.D.

Dr. Su was one of Agios’ founding scientists and its first employee. He served as senior vice president, research & development from 2012-2016. Dr. Su has more than 20 years of organization, project management and scientific experience in the biotechnology industry. Prior to Agios, from 2004 to 2006, he served as general director and vice president of the Biomedical Engineering Research Laboratory (BEL) at ITRI in Taiwan. Prior to that, he spent 14 years in a number of roles, concluding his tenure as program executive and vice president of the Novartis kinase collaboration for Vertex Pharmaceuticals, a publicly traded pharmaceutical company. Dr. Su earned his Ph.D. in biochemistry at Duke University and was a Helen Hay Whitney Fellow at Harvard University.